EUVIMEDScopri EUVIMED
BeobachtungsstudieOpen access · CC BY-NC-ND 4.0

How has the SARS‐CoV‐2 pandemic changed the epidemiology and management of acute bronchiolitis?

Giacomo Brisca iD, Marcello Mariani iD, Silvia Buratti, Marta Ferretti, Daniela Pirlo, Isabella Buffoni, Marisa Mallamaci, Pietro Salvati, Giulia Tagliarini, Emanuela Piccotti, Oliviero Sacco iD, Elio Castagnola and 1 more

Pediatric Pulmonology · 2023

DOI: 10.1002/ppul.26315 ↗

At a glance

Beobachtungsstudie in Pediatric Pulmonology, 2023. Written by Giacomo Brisca and 12 co-authors. Institution: Terapia Semintensiva, Dipartimento di Emergenza, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Major MEDLINE topics: COVID-19, Bronchiolitis, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Cited 23 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Objective

SARS‐COV‐2 pandemic profoundly impacted acute bronchiolitis epidemiology worldwide, especially respiratory syncytial virus (RSV) diffusion and the burden of disease, with remarkable implications on the management of health resources. We aimed to study the epidemiology and clinical course of bronchiolitis in the past 5 years in our region and to assess the trends that occurred during and after the SARS‐COV‐2 pandemic.

Methods

We conducted an observational study including all children aged 0–2 years with bronchiolitis admitted to a tertiary children's hospital during the last 5 years. Demographic, clinical, and microbiological data were collected. Comparisons between patient subgroups were carried out.

Results

A total of 647 patients admitted for bronchiolitis were included (median age 78 days). Molecular diagnostic tests were performed in 617 patients (95.4%) with RSV detected in 51.5% of patients in prepandemic years and 74.5% in pandemic years. Through the study period, we observed a progressive increase in the number of children requiring respiratory support, RSV infections, and children with a history of prematurity. Conversely, this was not true for mechanical ventilation, duration of respiratory support, intensive care unit admission, and length of stay.

Conclusions

Clinical course and epidemiology of bronchiolitis showed a significant change through the study years with a heavy impact during the 2021–2022 season. The increase in the number of patients requiring respiratory support, although not associated with an increase in mechanical ventilation, may be explained by the higher prevalence of RSV. The change in epidemiology highlights the importance of surveillance systems to monitor RSV circulation, to plan prophylactic strategies, and prepare healthcare systems.

Subjects

MeSH terms (MEDLINE)

COVID-19BronchiolitisRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanChildHumansInfantSARS-CoV-2PandemicsHospitalizationDisease Progression

Author keywords

SARS-CoV-2 pandemicbronchiolitisepidemiologypalivizumabrespiratory syncytial virus (RSV)

Authors and institutions

  • Terapia Semintensiva, Dipartimento di Emergenza, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Unità di Malattie Infettive e COVID Hospital, Dipartimento di Scienze Pediatriche, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Terapia Intensiva, Dipartimento di Emergenza, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Pediatria d'Urgenza e Pronto Soccorso, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Pronto Soccorso e Medicina d'Urgenza, Dipartimento di Emergenza, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Unità di Pneumologia Pediatrica e Endoscopica Respiratoria, Dipartimento di Scienze Pediatriche, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

ORCID profiles: Giacomo Brisca, Marcello Mariani, Oliviero Sacco

Cite

APA

Brisca, G., Mariani, M., Buratti, S., Ferretti, M., Pirlo, D., Buffoni, I., Mallamaci, M., Salvati, P., Tagliarini, G., Piccotti, E., Sacco, O., Castagnola, E., & Moscatelli, A. (2023). How has the SARS‐CoV‐2 pandemic changed the epidemiology and management of acute bronchiolitis?. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26315

Vancouver

Brisca G, Mariani M, Buratti S, Ferretti M, Pirlo D, Buffoni I, et al. How has the SARS‐CoV‐2 pandemic changed the epidemiology and management of acute bronchiolitis?. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26315

BibTeX
@article{Brisca2023,
  author = {Brisca, Giacomo and Mariani, Marcello and Buratti, Silvia and Ferretti, Marta and Pirlo, Daniela and Buffoni, Isabella and Mallamaci, Marisa and Salvati, Pietro and Tagliarini, Giulia and Piccotti, Emanuela and Sacco, Oliviero and Castagnola, Elio and Moscatelli, Andrea},
  title = {How has the SARS‐CoV‐2 pandemic changed the epidemiology and management of acute bronchiolitis?},
  journal = {Pediatric Pulmonology},
  year = {2023},
  doi = {10.1002/ppul.26315}
}
Start for free →